Bariatric Patients Clinical Trial
Official title:
Quality of Life and Cardiometabolic Risk Factors in Patients After Debanding
| Verified date | May 2016 |
| Source | University of Zurich |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Switzerland: Swissmedic |
| Study type | Observational |
Follow up of debanding patients
| Status | Completed |
| Enrollment | 12 |
| Est. completion date | February 2015 |
| Est. primary completion date | January 2015 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion criteria: - Previous debanding after lap. gastric bypass Exclusion criteria: - Further bariatric procedures |
N/A
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | University Hospital of Zurich | Zurich |
| Lead Sponsor | Collaborator |
|---|---|
| University of Zurich | Cantonal Hospital, Frauenfeld |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Quality of Life | 2 to 5 years after debanding | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01248312 -
Incidence of Hypercapnea in Morbidly Obese Post-Surgical Bariatric Patients Using the Sen Tec Transcutaneous PCO2 Monitor
|
N/A |